Is a complete NSE/POLYMED research report available?

No complete published report is available for nse/POLYMED (NSE/POLYMED) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/POLYMED stock profile: metrics, valuation and analysis

Market cap	176.1B
Revenue (ttm)	20B
Net income (ttm)	3.2B
EPS (ttm)	₹31.1
P/E (trailing)	55.9x
P/E (forward)	39.9x
Dividend	₹3.50 (0.20%)
Volume	69,946
Beta	0.01

All NSE/POLYMED indicators

Market & fundamental data

Available fields

215

Groups with data

Currency

INR

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	2,614
Employees Change	-468%
Employees Change Percent	-15.18
Enterprise value	INR 171.8B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	INE205C01021
Last refreshed	2026-09-12
Market cap	INR 176.1B
Price	INR 1,739
Price currency	INR
Rev Per Employee	7,641,254.78x
Sector	Healthcare
Sector PE	47.81
Sector PE Fwd	38.12
Sic	3841
Symbol	nse/POLYMED
Website	https://www.polymedicure.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.79%
EV Earnings	54.52x
EV/EBIT	50.72x
EV/EBITDA	37.11x
EV/Sales	8.6x
FCF yield	-0.35%
Forward P/E	39.92x
P/B ratio	5.59x
P/E ratio	55.89x
P/S ratio	8.82x
PE Ratio10 Y	43.75x
PE Ratio3 Y	61.09x
PE Ratio5 Y	59.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.66%
EBITDA Margin	22.88%
Gross margin	69.49%
Gross Profit	INR 13.9B
Gross Profit Growth	22.34%
Gross Profit Growth Q	39.73%
Gross Profit Growth3 Y	22.14%
Gross Profit Growth5 Y	20.22%
Net Income	INR 3.2B
Net Income Growth	-11.89%
Net Income Growth Q	-7.58%
Net Income Growth Qo Q	29.77%
Net Income Growth Years	0%
Net Income Growth3 Y	13.58%
Net Income Growth5 Y	16.51%
Pretax Margin	21.12%
Profit Margin	15.77%
Profit Per Employee	INR 1.2M
Profitable Quarters	INR 39
Profitable Years	21
Roa5y	8.49
Roe5y	15.11
ROIC	9.22
Roic5y	15.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	25.04%
Cagr1y	-10.38%
Cagr3y	8.06%
Cagr5y	12.41%
Div CAGR10	8.84%
Div CAGR3	5.27%
Div CAGR5	6.96%
EPS Growth	-12.6
EPS Growth Q	-7.53
EPS Growth Qo Q	29.95
EPS Growth Years	0
EPS Growth3 Y	11.53
EPS Growth5 Y	14.03
OCF Growth	5.72%
OCF Growth10 Y	37.96%
OCF Growth3 Y	8.85%
OCF Growth5 Y	15.72%
Revenue Growth	18.31x
Revenue Growth Q	30.3x
Revenue Growth Qo Q	-1.71x
Revenue Growth Quarters	25x
Revenue Growth Years	20x
Revenue Growth3 Y	18.94x
Revenue Growth5 Y	19.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 8.3B
Debt	INR 3.5B
Debt EBITDA	INR 0.77
Debt Equity	INR 0.11
Debt FCF	INR -5.7
Equity	INR 31.5B
Interest Coverage	15.24
Net Cash	INR 4.7B
Net Cash By Market Cap	INR 2.69
Net Cash Growth	-53.93%
Net Debt EBITDA	INR -1.04
Net Debt Equity	INR -0.15
Tangible Book Value	INR 26.7B
Tangible Book Value Per Share	INR 263
WACC	4.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.82%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	INR 3.5
Dividend Years	22
Dividend Yield	0.2%
Ex Div Date	2026-08-28
Last Dividend	INR 3.5
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	833.65%
1Y total return	-10.37%
200-day SMA	1,587.6
3Y total return	26.17%
50-day SMA	1,719.3
50-day SMA vs 200-day SMA	50over200
5Y total return	79.43%
All Time High	3,357.8
All Time High Change	-48.21%
All Time High Date	2024-11-01
All Time Low	22.64
All Time Low Change	7,581.77%
All Time Low Date	2011-12-21
ATR	60.42
Beta	0.01
Ch YTD	-1.96
High	1,741.2
High52	2,107.8
High52 Date	2025-09-18
High52ch	-17.5%
Low	1,709.7
Low52	1,182
Low52 Date	2026-03-30
Low52ch	47.12%
Ma50ch	1.14%
Price vs 200-day SMA	9.53%
RSI	50.9
RSI Monthly	49.82
RSI Weekly	56.08
Sharpe ratio	-0.25x
Sharpe Ratio3y	0.28x
Sharpe Ratio5y	0.43x
Sortino ratio	-0.23
Sortino Ratio3y	0.58
Sortino Ratio5y	0.85
Total Return	-0.61%
Tr YTD	-1.76
Tr1m	-1.68%
Tr1w	2.14%
Tr3m	22.93%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	36,344,080%
Net Borrowing	712,378,000
Shares Insiders	36.98%
Shares Institutions	20.45%
Shares Qo Q	-0.07%
Shares Yo Y	0.82%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR -694.3M
Adjusted OCF	2,389,658,000
Average Volume	166,719.65x
Bv Per Share	306.4
CAPEX	INR -3.1B
Ch10y	792.4
Ch1m	-1.88
Ch1w	2.14
Ch1y	-10.71
Ch3m	22.68
Ch3y	25.28
Ch5y	77.22
Ch6m	35.48
Change	-0.5%
Change From Open	-0.06
Close	1,747.7
Days Gap	-0.43
Depreciation Amortization	1,242,689,750
Dollar Volume	121,636,094
Earnings Date	2026-11-06
EBIT	INR 3.3B
EBITDA	INR 4.6B
EPS	INR 31.06
F Score	3
FCF	INR -620.2M
FCF EV Yield	-0.36x
Financing CF	201,514,000
Fiscal Year End	March
Founded	1,995
Graham Number	466.60988
Graham Upside	-73.17
Income Tax	INR 1.1B
Investing CF	-2,253,811,000
Is Primary Listing	0
Last Earnings Date	2026-08-07
Last Report Date	2026-06-30
Last Split Date	2017-03-24
Last Split Type	Forward
Lynch Fair Value	INR 514
Lynch Upside	-70.46
Ma150	1,530.3
Ma150ch	13.64%
Ma20	1,740.8
Ma20ch	-0.1%
Net CF	425,294,000
Next Earnings Date	2026-11-06
Open	1,740.1
P OCF Ratio	71.48
P OCF Ratio SBC	73.69
Payment Date	2026-10-05
Position In Range	93.02
Price Date	2026-09-11
Price EBITDA	INR 38.53
Ptbv Ratio	6.6
Relative Volume	0.42x
Revenue	19,974,240,000x
SBC By Revenue	0.4x
Share Based Comp	74,088,000
Tax By Revenue	5.45x
Tax Rate	25.82%
Tr6m	35.76%
Volume	69,946

NSE/POLYMED (NSE/POLYMED)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/POLYMED

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/POLYMED indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/POLYMED

Frequently asked questions